Dr Rider is a research scientist resident in Cambridge, United Kingdom, where he is involved in developing biological therapeutics for respiratory and inflammatory diseases for a multinational pharmaceutical company. For his PhD, he investigated the role of the inflammatory microenvironment on T cell function in rheumatoid arthritis. Dr Rider was a post-doctoral fellow in the UK and Singapore, studying a diverse range of cell biology and immunology topics, including mesenchymal and hematopoietic stem cells. He has published 10 papers in international peer-reviewed journals, and presented his research at several international conferences. Dr Rider began editing for the Edanz Group in 2009.